The history of psilocybin research
Psychedelics have been consumed and used by human beings since before recorded history. Whether in natural form (psilocybin, mescalin, ayahuasca, etc.), or synthetic (MDMA, LSD, etc.), scientists have long wondered about their potential benefits for the human mind. While research papers have discussed their benefits since the discovery of MDMA in the 1910s and the discovery of LSD in 1938, we focus on the research that emerged after the “dark period” that started with the UN Convention on Psychotropic Substances of 1971.
Probably the most important body of psychedelic research comes from the Multidisciplinary Association for Psychedelic Studies (MAPS).
For almost 40 years, MAPS has led the way with world class research into many different psychedelic molecules. MAPS has conducted many studies with MDMA and other psychedelics, producing great results and publications. The studies have shown such promise that they formally submitted to the FDA for approval of MDMA for the treatment of PTSD.
You can review a great summary of psilocybin research on the MAPS website. Note: even though this submission was recently rejected by the FDA, we expect MAPS (now known as Lykos) to continue with another submission that addresses the FDA’s concerns.
Johns Hopkins University is one the most famous centers for modern psychedelic research. Dr. Roland Griffiths led decades of research about psychedelics across many disease states.
Learn more about Johns Hopkins Research and the history of psilocybin research. Johns Hopkins is also one of the flagship research centers to research psilocybin for cancer.
Continue Learning from Sachi
For a great survey of psychedelic research conducted through 2022, you can catch up with this comprehensive report from the Homewood Research Institute at Queen’s University (Ontario, Canada): full report or summary of key findings
The history of psilocybin research
Psychedelics have been consumed and used by human beings since before recorded history. Whether in natural form (psilocybin, mescalin, ayahuasca, etc.), or synthetic (MDMA, LSD, etc.), scientists have long wondered about their potential benefits for the human mind. While research papers have discussed their benefits since the discovery of MDMA in the 1910s and the discovery of LSD in 1938, we focus on the research that emerged after the “dark period” that started with the UN Convention on Psychotropic Substances of 1971.
Probably the most important body of psychedelic research comes from the Multidisciplinary Association for Psychedelic Studies (MAPS).
For almost 40 years, MAPS has led the way with world class research into many different psychedelic molecules. MAPS has conducted many studies with MDMA and other psychedelics, producing great results and publications. The studies have shown such promise that they formally submitted to the FDA for approval of MDMA for the treatment of PTSD.
You can review a great summary of psilocybin research on the MAPS website. Note: even though this submission was recently rejected by the FDA, we expect MAPS (now known as Lykos) to continue with another submission that addresses the FDA’s concerns.
Johns Hopkins University is one of the most famous centers for modern psychedelic research. Dr. Roland Griffiths led decades of research about psychedelics across many disease states.
Learn more about 
Johns Hopkins Research and the history of psilocybin research. Johns Hopkins is also one of the flagship research centers to research psilocybin for cancer.
Continue Learning from Sachi
For a great survey of psychedelic research conducted through 2022, you can catch up with this comprehensive report from the Homewood Research Institute at Queen’s University (Ontario, Canada): 
full report or summary of key findings